Research Progress Regarding the Effect and Mechanism of Dietary Polyphenols in Liver Fibrosis
-
Published:2023-12-25
Issue:1
Volume:29
Page:127
-
ISSN:1420-3049
-
Container-title:Molecules
-
language:en
-
Short-container-title:Molecules
Author:
Chang Jiayin1,
Huang Congying1,
Li Siqi1,
Jiang Xiaolei1,
Chang Hong1,
Li Minhui123ORCID
Affiliation:
1. Department of Pharmacy, Baotou Medical College, Baotou 014040, China
2. Inner Mongolia Autonomous Region Hospital of Traditional Chinese Medicine, Hohhot 010020, China
3. Inner Mongolia Key Laboratory of Characteristic Geoherbs Resources Protection and Utilization, Baotou 014040, China
Abstract
The development of liver fibrosis is a result of chronic liver injuries may progress to liver cirrhosis and liver cancer. In recent years, liver fibrosis has become a major global problem, and the incidence rate and mortality are increasing year by year. However, there are currently no approved treatments. Research on anti-liver-fibrosis drugs is a top priority. Dietary polyphenols, such as plant secondary metabolites, have remarkable abilities to reduce lipid metabolism, insulin resistance and inflammation, and are attracting more and more attention as potential drugs for the treatment of liver diseases. Gradually, dietary polyphenols are becoming the focus for providing an improvement in the treatment of liver fibrosis. The impact of dietary polyphenols on the composition of intestinal microbiota and the subsequent production of intestinal microbial metabolites has been observed to indirectly modulate signaling pathways in the liver, thereby exerting regulatory effects on liver disease. In conclusion, there is evidence that dietary polyphenols can be therapeutically useful in preventing and treating liver fibrosis, and we highlight new perspectives and key questions for future drug development.
Funder
National Natural Science Foundation of China
Inner Mongolia Natural Science Foundation Project
Program for Young Talents of Science and Technology in Universities of Inner Mongolia Autonomous Region
Inner Mongolia Autonomous Region Chinese Medicine (Mongolian Medicine) Young and Middle-aged Leading Talents Cultivation Project
“Innovation Team Development Plan” of Colleges and Universities in Inner Mongolia Autonomous Region
Alxa League Science and Technology Program
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Reference178 articles.
1. Global Epidemiology of Chronic Liver Disease;Cheemerla;Clin. Liver Dis.,2021
2. Hepatic fibrosis 2022: Unmet needs and a blueprint for the future;Friedman;Hepatology,2022
3. New Drugs for Hepatic Fibrosis;Shan;Front. Pharmacol.,2022
4. Tan, Z., Sun, H., Xue, T., Gan, C., Liu, H., Xie, Y., Yao, Y., and Ye, T. (2021). Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy. Front. Cell Dev. Biol., 9.
5. Management Strategies for Liver Fibrosis;Ann. Hepatol.,2017